Inhibitory effect of Carthamus tinctorius L. seed extracts on bone resorption mediated by tyrosine kinase, COX-2 (cyclooxygenase) and PG (prostaglandin) E2

American Journal of Chinese Medicine

Volumn 30, Issue 1, 2002, Pages 95-108

  Yuk, Tae Han ^a   Kang, Joon Hyeog ^a   Lee, Sang Ryoung ^a   Yuk, Sang Won ^a   Lee, Kwang Gyu ^a   Song, Beum Yong ^a   Kim, Cheorl Ho ^b   Kim, Dong Wook ^b   Kim, Dong Il ^b   Lee, Tae Kyun ^b   Lee, Chang Hyun ^a  

^a Woosuk University College of Oriental Medicine   (South Korea)

^b Dongguk University   (South Korea)

Author keywords

Bone Resorption; Carthamus tinctorius; Cox 2; Prostaglandin E; Tyrosine Kinase

Indexed keywords

CYCLOOXYGENASE 2; HERBIMYCIN A; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROSTAGLANDIN E2; PROTEIN TYROSINE KINASE; SAFFLOWER OIL; TUMOR NECROSIS FACTOR ALPHA; BENZOQUINONE DERIVATIVE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; HERBIMYCIN; ISOENZYME; MACROCYCLIC LACTAM; MEMBRANE PROTEIN; MESSENGER RNA; PARATHYROID HORMONE; PLANT EXTRACT; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PTGS1 PROTEIN, MOUSE; QUINONE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METABOLISM; CALVARIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ENZYME INHIBITION; FETUS; GENE EXPRESSION; HYPERCALCEMIA; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; OVARIECTOMY; RAT; SAFFLOWER; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; BLOOD; BONE; CARTHAMUS; CELL CULTURE; CELL SEPARATION; CELL SURVIVAL; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG ANTAGONISM; FEMALE; MALE; METABOLISM; OSTEOPOROSIS; PATHOLOGY; PLANT SEED;

ANIMALS; BENZOQUINONES; BONE AND BONES; BONE RESORPTION; CARTHAMUS; CELL SEPARATION; CELL SURVIVAL; CELLS, CULTURED; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; CYTOKINES; DINOPROSTONE; FEMALE; HYPERCALCEMIA; ISOENZYMES; LACTAMS, MACROCYCLIC; MALE; MEMBRANE PROTEINS; MICE; OSTEOBLASTS; OSTEOPOROSIS; OVARIECTOMY; PARATHYROID HORMONE; PLANT EXTRACTS; PROSTAGLANDIN ANTAGONISTS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN-TYROSINE KINASES; QUINONES; RNA, MESSENGER; SEEDS;

EID: 18744390847     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X02000119     Document Type: Article

References (34)

1. Baron, R., J.H. Ravesloot, L. Neff, M. Chakraborty, D. Chatterjee, A. Lomri and W. Horne. Cellular and molecular biology of the osteoclast. In: M. Noda (ed.) Cellular and Molecular Biology of Bone. Academic Press, San Diego, CA, 1993, pp. 445-495.
2. Boyce, B.F., T. Yoneda, C. Lowe, P. Soriano and G.R. Mundy. Requirement of pp60c-Src expression for osteoclasts to form ruffled borders and resorb bone in mice. J. Clin. Invest. 90:1622-1627, 1992.
3. Canalis, E. and S. Rydziel. Platelet-derived growth factor and the skeleton. In: J.P. Bilezikian, L.G. Raisz and G.A. Rodan (eds.) Principles of Bone Biology. Academic Press, San Diego, CA, 1996, pp. 619-626.
4. Gunness-Hey, M. and J.M. Hock. Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone. Metab. Bone Dis. Rel. Res. 5: 177-181, 1984.
5. Hong, H.T. Effects of Yukmijihangtang-Jahage Extracts on Cellular Regulation of Bone Cell and Function. Thesis of Ph.D. Dongguk University, Kyungju, Korea, 1998.
6. Horne, W.C., L. Neff, D. Chatterjee, A. Lomri, J.B. Levy and R. Baron. Osteoclasts express high levels of pp60c-Src in association with intracellular membranes. J. Cell. Biol. 119: 1003-1013, 1992.
7. Izbicka, E., M. Niewolna, T. Yoneda, C. Lowe, B. Boyce and G. Mundy. pp60c-Src expression and activity in MG-63 osteoblastic cells modulated by PTH but not required for PTH-mediated adenylate cyclase response. J. Bone Miner. Res. 9: 127-132, 1994.
8. Jamall, I.S., V.N. Finelli and S.S. Que Hee. A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal. Biochem. 112: 70-75, 1981.
9. Kim, H.M, C.S An, K.Y Jung, Y.K Choo, J.K. Park and S.Y. Nam. Rehmannia Glutinosa inhibits tumor necrosis factor-alpha and interleukin-1 secretion from mouse astrocytes. Pharmacol. Res. 40: 171-176, 1999.
10. Klohs, W.D., D.W. Fry and A.J. Kraker. Inhibitors of tyrosine kinase. Ciirr. Opin. Oncol. 9: 562-568, 1997.
11. Kuroki, Y., S. Shiozawa, T. Sugimoto and T. Fijita. Constitutive expression of c-fos gene inhibits type-I collagen synthesis in transfected osteoblasts. Biochem. Biophys. Res. Comm. 182:1389-1394, 1992.
12. Lowe, C., T. Yoneda, B.F. Boyce, H. Chen, G.R. Mundy and P. Soriano. Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts. Proc. Natl. Acad. Sci. 90: 4485-4489, 1992.
13. Mundyln, G.R. Bone Remodeling and Its Disorders. Martin Dunitz Ltd, London, UK 1995, pp. 50-53.
14. Park, C., J.K. Shim, K.S. Nam, Y.C. Lee and C.H. Kim. Inhibitory effects of streptozotocin, tumor necrosis factor-α, and interleukin-1β on glucokinase activity in pancreatic islets and gene expression of GLUT2 and glucokinase. Arch. Biochem. Biophys. 362: 217-224, 1999a.
15. Park C., J.R. Kim, J.K. Shim, B.S. Kang, Y.G. Park, K.S. Nam, Y.C. Lee and C.H. Kim. 1999. Inhibitory effects og streptozotocin, tumor necrosis factor-α, and interleukin-1β on glucokinase activity in pancreatic islets and gene expression of GLUT2 and glucokinase. Arch. Biochem. Biophys. 362: 217-224, 1999b.
16. Park, J.I., T.K. Lee, J.K. Kim, D.Y. Choi and C.H. Kim. Immune-stimulating properties of polysaccharides from P. cortex. Glycoconjugate J. 16: 247-252, 1999c.
17. Parsons, J.T. and S.J. Parsons. Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways. Curr. Opin. Cell. Biol. 9: 187-192, 1997.
18. Phillipson, J.D. and L.A. Anderson. Ethnopharmacology and western medicine. J. Ethnopharmacol. 25: 61-72, 1989.
19. Rodan, G.A., L.G. Raisz and J.P. Bilezikian. Pathophysiology of osteoporosis. In: J.P. Bilezikian, L.G. Raisz and G.A. Rodan (eds.), Principles of Bone Biology. Academic Press, San Diego, CA, 1996, pp. 979-990.
20. Roodman, G.D. Advances in bone biology: the osteoclast. Endocrinol. Rev. 17: 308-332, 1996.
21. Rueggsegger, P., B. Koller and R. Muller. A microtomographic system for the nondestructive evaluation of bone architecture. Calcif. Tissue Int. 58: 24-29, 1996.
22. Sabatini, M., B. Boyce, T. Aufdemorte, L. Bonewald and R.G. Mundy. Infusions of recombinant human interleukin 1α and 1β cause hypercalcemia in normal mice. Proc. Natl. Acad. Sci. 85: 5235-5239, 1988.
23. Sambrook, J., E.F. Fritsch, and T. Maniatis. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor, New York, 1988.
24. Serban, D. and C. Rordorf-Adam. Quantitation of serum amyloid P component by an enzyme-linked immunoassay. J. Immunol. Meth. 90: 159-164, 1986.
25. Shi, X.C. Chinese-English Terminology of Traditional Chinese Medicine. Human Science Publishing Co. China, 1983, pp. 71-98.
26. Songyang, Z., K.L. Carraway, III, M. Eck, S.C. Harrison, R.A. Feldman, M. Mohammadi, J. Schlessinger, S.R. Hubbard, D.P. Smith, C. Eng, M.J. Lorenzo, B.A.J. Ponder, B.J. Mayer and L.C. Cantley. Catalytic specificity of protein-tyrosine kinases is critical for selective signaling. Nature 373: 536-539, 1995.
27. Soriano, P., C. Montgomery, R. Geske and A. Bradley. Targeted disruption of the c-Src proto-oncogene leads to osteopetrosis in mice. Cell 64: 693-702, 1991.
28. Stein, B. and M.S.K. Sutherland. IL-6 as a drug discovery target. Drug Discovery Today 3: 202-213, 1998.
29. Stein, P.L., H. Vogel and P. Soriano. Combined deficiencies of Src, Fyn and Yes tyrosine kinases in mutant mice. Genes Dev. 8: 1999-2007, 1994.
30. Tanaka, S.N., N. Takahashi, T. Udagawa, Y. Sasaki, T. Fukui, T. Kurokawa and T. Suda. Osteoclasts express high levels of pp60c-Src, preferentially on ruffled border membrane. FEBS Lett. 313: 85-89, 1992.
31. Thomas, S.M. and J.S. Brugge. Cellular functions regulated by Src family kinases. Annu. Rev. Cell. Dev. Biol. 13: 513-609, 1997.
32. Ua, M., G.J. Standke, M. Jeschke and D. Rohner. Fluoroaluminate induces pertussis toxin-sensitive protein phosphorylation: differences in MC3T3-E1 osteoblastic and NIH3T3 fibroblastic cells. Biochem. Biophys. Res. Commun. 235: 680-684, 1997.
33. Uy, H.L., M. Dallas, J.W. Calland, B.F. Boyce, G.R. Mundy and G.D. Roodman. Use of an in vivo model to determine the effects of interleukin-1 on cells at different stages in the osteoclast lineage. J. Bone Miner. Res. 10: 295-301, 1995.
34. Yucel-Lindberg, T., H. Ahola, J. Carlstedt-Duke and T. Modeer. Involvement of tyrosine kinases on cyclooxygenase expression and prostaglandin E2 production in human gingival fibroblasts stimulated with interleukin-1β and epidermal growth factor. Biochem. Biophys. Res. Comm. 257: 528-532, 1999.